About Index Trending news
Analyze
Top 50 Pricing
Armune BioScience

Armune BioScience

Work at Armune BioScience? Add yourself to this profile

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.

Elsewhere

Alexa global traffic share

Twitter followers

07 Sep 2016
$5,000,000
Venture capital (Series A)
Grand Angels Venture Fund II

Armune BioScience Closes $5M Series A Funding

FinSMEs
12 Jul 2016
$9,710,000
Venture capital (Series A)

Medical diagnostics startup secures $9M in funding

grbj
+2
20 Jan 2015
$3,537,583
Venture capital
22 Dec 2010
$250,000
Debt financing
25 Aug 2008
Venture capital